Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Boldt

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|June 8, 2004
Targeting MAPK signalling: Prometheus' fire or Pandora's box?Simone Boldt, Walter Kolch
Experimental Cell Research|February 5, 2003
The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathwaysSimone Boldt, Ulrich H Weidle, Walter Kolch
Carcinogenesis|November 7, 2002
The role of MAPK pathways in the action of chemotherapeutic drugsSimone Boldt, Ulrich H Weidle, Walter Kolch
Journal of Leukocyte Biology|November 13, 2003
LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathwaySilvia Kirchner, Simone Boldt, Walter Kolch, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|June 8, 2004
Targeting MAPK signalling: Prometheus' fire or Pandora's box?Simone Boldt, Walter Kolch
Experimental Cell Research|February 5, 2003
The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathwaysSimone Boldt, Ulrich H Weidle, Walter Kolch
Carcinogenesis|November 7, 2002
The role of MAPK pathways in the action of chemotherapeutic drugsSimone Boldt, Ulrich H Weidle, Walter Kolch
Journal of Leukocyte Biology|November 13, 2003
LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathwaySilvia Kirchner, Simone Boldt, Walter Kolch, et al.
Pageof 1